Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant

International Journal of Pharmaceutics

Volumn 316, Issue 1-2, 2006, Pages 124-130

  Takatsuka, Shinya ^a   Morita, Takahiro ^a   Koguchi, Atsushi ^a   Horikiri, Yuji ^a   Yamahara, Hiroshi ^a   Yoshino, Hiroyuki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Mucolytic agent; Non ionic surfactant; Peroral delivery; Salmon calcitonin; Simultaneous use

Indexed keywords

ACETYLCYSTEINE; CITRIC ACID; DEOXYCHOLATE SODIUM; MUCOLYTIC AGENT; NONIONIC SURFACTANT; SALCATONIN; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TRITON X 100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; JEJUNUM; MALE; MORPHOLOGY; MUCOSAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SALMON;

ACETYLCYSTEINE; ANIMALS; AREA UNDER CURVE; CALCITONIN; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; EXPECTORANTS; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MALE; OCTOXYNOL; RATS; RATS, WISTAR; SURFACE-ACTIVE AGENTS;

EID: 33646814007     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.053     Document Type: Article

References (26)

1. Asada H., Douen T., Waki M., Adachi S., Fujita T., Yamamoto A., and Muranishi S. Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. J. Pharm. Sci. 84 (1995) 682-687
2. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
3. Bernkop-Schnürch A., and Fragner R. Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm. Sci. 2 (1996) 361-363
4. Bernkop-Schnürch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release 52 (1998) 1-16
5. Iiboshi Y., Nezu R., Cui L., Chen K., Khan J., Yoshida H., Sando K., Kamata S., Takagi Y., and Okada A. Adhesive mucous gel layer and mucus release as intestinal barrier in rats. J. Parenter. Enter. Nutr. 20 (1996) 98-104
6. Janes K.A., Calvo P., and Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47 (2001) 83-97
7. Lee C.J., Seok J.H., Hur G.M., Lee J.H., Park J.S., Seol I.C., and Kim Y.H. Effects of ursolic acid, betulin and sulfur-containing compounds on micin release from airway goblet cells. Planta Med. 70 (2004) 1119-1122
8. Lee V.H.L., and Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Deliv. Rev. 4 (1990) 171-207
9. Lee V.H.L., Yamamoto A., and Kompella U.B. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 91-192
10. Lee Y.H., Perry B.A., Labruno S., Lee H.S., Stern W., Falzone L.M., and Sinko P.J. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs. Pharm. Res. 16 (1999) 1233-1239
11. Michael S., Thöle M., Dillmann R., Fahr A., Drewe J., and Fricker G. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine. Eur. J. Pharm. Sci. 10 (2000) 133-140
12. Oberle R.L., Moore T.J., and Krummel D.A.P. Evaluation of mucosal damage of surfactants in rat jejunum and colon. J. Pharmacol. Toxicol. Methods 33 (1995) 75-81
13. Quan Y., Hattori K., Lundborg E., Fujita T., Murakami M., Muranishi S., and Yamamoto A. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers. Biol. Pharm. Bull. 21 (1998) 615-620
14. Sakai M., Imai T., Ohtake H., and Otagiri M. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J. Pharm. Pharmcol. 50 (1998) 1101-1108
15. Sakuma S., Hayashi M., and Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv. Drug Deliv. Rev. 47 (2001) 21-37
16. Sinko P.J., Lee Y.H., Makhey V., Leesman G.D., Sutyak J.P., Yu H., Perry B., Smith C.T., Hu P., Wagner E.J., Falzone L.M., McWhorter L.T., Gilligan J.P., and Stern W. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In vitro permeability and in vivo oral absorption of salmon calcitonin (SCT). Pharm. Res. 16 (1999) 527-533
17. Swenson E.S., and Curatolo W. Intestinal permeability enhancement for proteins, peptides, and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8 (1992) 39-92
18. Swenson E.S., Milison W.B., and Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 11 (1994) 1132-1142
19. Swenson E.S., Milisen W.B., and Curatolo W. Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers. Pharm. Res. 11 (1994) 1501-1504
20. Takahashi K., Numata N., Kinoshita N., Utoguchi N., Mayumi T., and Mizuno N. Characterization of the influence of nitric oxide donors on intestinal absorption of macromolecules. Int. J. Pharm. 286 (2004) 89-97
21. Takatsuka S., Kitazawa T., Morita T., Horikiri Y., and Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur. J. Pharm. Biopharm. 62 (2006) 52-58
22. Thanou M., Verhoef J.C., and Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52 (2001) 117-126
23. Torres-Lugo M., and Peppas N.A. Transmucosal delivery system for calcitonin: a review. Biomaterials 21 (2000) 1191-1196
24. Wang J., Chow D., Heiati H., and Shen W.C. Reversible lipidization for the oral delivery of salmon calcitonin. J. Control. Release 88 (2003) 369-380
25. Yamamoto A., Uchiyama T., Nishikawa R., Fujita T., and Muranishi S. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J. Pharm. Pharmcol. 48 (1996) 1285-1289
26. Yamamoto A., Tatsumi H., Maruyama M., Uchiyama T., Okada T., and Fujita T. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J. Pharmacol. Exp. Ther. 296 (2001) 84-90